Related topics

Panel Says Change Claritin Status

May 11, 2001

%mlink(STRY:; PHOTO:; AUDIO:%)

GAITHERSBURG, Md. (AP) _ A Food and Drug Administration advisory panel recommended Friday that the popular allergy drug Claritin be made available without prescription.

The 19-4 vote came on a request by a California health insurance company, which said the medication was safe and could be used by patients without consulting doctors.

The panel also was considering taking similar action on two other allergy drugs, Zyrec and Allegra.

The FDA is not required to follow the recommendations of the panel, but usually does so.

Update hourly